Dalip Sethi, Ph.D. and Joy Duemke, at Terumo Blood and Cell Technologies explore how automated apheresis platforms function as a therapeutic and an enabling technology for cell-based therapies.
Bristol Myers Squibb have announced a $400 million investment in their Dublin 15 Cruiserath Campus towards the build and design of a Sterile Drug Product facility.
Niall Balfour, Chief Executive Officer at Tower Cold Chain, explores the sustainability implications associated with both single-use, semi-reusable and fully reusable temperature-controlled shippers.
Takeda and Biological E. Limited, an India-based vaccines and pharmaceutical company, have announced a strategic partnership to accelerate access to QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials.
Ralph Howes, Cold Store Major Accounts Manager, ICS Cool Energy gives us 5 top tips for reducing costs process cooling systems in our latest EPM Online Insight.
Penny Pinnock, Siemens Financial Services, explores how more efficient and accurate technology is contributing to improved healthcare outcomes and helping private hospital groups cope with supporting NHS backlog.
In our latest EPM Online Insight, Andy Clarke, Country Manager (UK), at YSDS explores the complexities and demands of low volume, high value shipments through specialist logistics support.
Bryan Hill (Global / Americas), Gaga Syal (GGM) & Rohit Alimchandani (UK) - Cognizant discuss how life sciences organisations should prepare for the quantum revolution in our latest EPM Online Insights.
FUJIFILM Healthcare Europe has unveiled the ECHELON Synergy, a revolutionary MRI scanner for efficient, high performance imaging with optimal patient comfort.
Jimin Kim, Senior CDO Business Strategist at Samsung Biologics, lays out the challenges of successfully progressing complex biologics from clinic to commercialisation.
In our latest EPM Online Insight, ACG's Subhashis Chakraborty and Shincy Jacob attempt to answer what groundbreaking innovations lie ahead for capsules, and how will these developments redefine their role in the evolving landscape of drug delivery?
